1. ALLA AKTIER
  2. NYHETER
  3. VIMIAN

Vimian

Nyheter Vimian Nyheter alla bolag

Vimian Group AB (publ) publishes prospectus in connection with its listing on Nasdaq Stockholm’s Main Market

MARKN.

Vimian Group AB (publ) (”Vimian” or the ”Company”) announced on 14 March 2025 that Nasdaq Stockholm’s listing committee had approved Vimian’s application to admit the Company’s ordinary shares to trading on Nasdaq Stockholm’s Main Market. The prospectus that has been prepared in connection with the uplisting has today been approved and registered by the Swedish Financial Supervisory Authority (the “SFSA”) and is now available on Vimian’s website, www.vimian.com, and on the SFSA’s website, www.fi.se.

The first day of trading on Nasdaq Stockholm is expected to be Friday, 28 March 2025 and the last day of trading on Nasdaq First North Growth Market is expected to be Thursday, 27 March 2025. Vimian’s ordinary shares will be traded in the Large Cap segment with unchanged ticker (VIMIAN) and unchanged ISIN code (SE0015961982). There will be no offer or issuance of new shares in connection with the change of marketplace to Nasdaq Stockholm and shareholders in Vimian do not need to take any action in connection therewith.

Advokatfirman Vinge is acting as legal advisor to Vimian in connection with the listing on Nasdaq Stockholm.

For further information, please contact:

Maria Dahllöf Tullberg
Head of IR, Communications & Sustainability
maria.tullberg@vimian.com
+46 736 26 88 86

About Vimian

Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Veterinary Services and Diagnostics. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market’s most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 17,000 veterinary clinics and laboratories, sells to over 80 markets, has 1,200 employees and annual revenues of approximately EUR 375 million. For more information, please visit: www.vimian.com. FNCA Sweden AB is appointed the Company’s Certified Adviser.

Attachments

Vimian Group AB (publ) publishes prospectus in connection with its listing on Nasdaq Stockholm’s Main Market
Vimian Prospectus

Datum 2025-03-21, kl 11:15
Källa MFN
Bifogade filer
Vimian Group AB (publ) publishes prospectus in connection with its listing on Nasdaq Stockholm’s Main Market
Vimian Prospectus
Affiliate
Alla Aktier tipsar: Har du redan ett konto på Avanza? Varför inte skapa ett på Nordnet också och jämföra funktioner, courtage mm. Det tar inte lång tid, du fixar det direkt här med BankID
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet